Jun 13, 2025 07:16AM
Jun 3, 2025 06:21AM
Jun 2, 2025 10:01AM
Jun 2, 2025 10:00AM
May 28, 2025 05:39AM
May 21, 2025 12:18PM
May 21, 2025 12:17PM UroGen Announces Outcome of Oncologic Drugs Advisory Committee for UGN-102 for the Treatment of Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)
May 12, 2025 08:00AM
May 7, 2025 08:57AM
May 7, 2025 08:57AM
Apr 27, 2025 01:00PM
Apr 27, 2025 12:30PM
Apr 26, 2025 06:30PM
Apr 14, 2025 08:00AM UroGen Announces Data Presentations at the American Urological Association 2025 Annual Meeting Highlighting Emerging Evidence Supporting Our Portfolio for Urothelial Cancers
Mar 10, 2025 08:00AM
Feb 14, 2025 02:30PM
Feb 14, 2025 02:30PM
Jan 15, 2025 08:05AM
Jan 15, 2025 08:00AM
Dec 5, 2024 03:22PM
Dec 5, 2024 03:15PM UGN-102 Showed Promising Long-Term Results in the Phase 3 ENVISION Trial, Potentially Paving the Way for First FDA-Approved Treatment for LG-IR-NMIBC
Dec 2, 2024 08:00AM
Nov 6, 2024 08:00AM
Oct 15, 2024 04:31PM
Oct 15, 2024 04:30PM
Aug 16, 2024 06:47AM
Mar 23, 2020 08:00AM
Mar 2, 2020 08:00AM UroGen Pharma Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Corporate Developments
Jan 13, 2020 07:47AM
Dec 19, 2019 08:02AM
Dec 19, 2019 08:00AM

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All